Literature DB >> 12439895

Juvenile myoclonic epilepsy: linkage to chromosome 6p12 in Mexico families.

Dongsheng Bai1, Maria E Alonso, Marco T Medina, Julia N Bailey, Ryoji Morita, Sergio Cordova, Astrid Rasmussen, Jaime Ramos-Peek, Adriana Ochoa, Aurelio Jara, Francisco R Donnadieu, Gilbert Cadena, Kazuhiro Yamakawa, Antonio V Delgado-Escueta.   

Abstract

Juvenile myoclonic epilepsy is a common subtype of idiopathic epilepsy accounting for 4-11% of all epilepsies. We reported previously significant evidence of linkage between chromosome 6p12-11 microsatellites and the clinical epilepsy and EEG traits of JME families from Belize and Los Angeles. To narrow the JME region, we ascertained and genotyped 31 new JME families from Mexico using a later generation of Généthon microsatellites. Two point linkage analyses obtained significant Z(max) values of 3.70 for D6S1573 and 2.65 for D6S1714 at theta(m = f) = 0.10, and 3.49 for D6S465, 2.11 for D6S1960 at theta(m = f) = 0.05 assuming autosomal dominant inheritance with 70% age-dependent penetrance. Multipoint LOD score curve peaked at 4.21 for D6S1573. Haplotype and recombination analysis reduced the JME region to 3.5 cM flanked by D6S272 and D6S1573. These results provide confirmatory evidence that a major susceptibility gene for JME exists in chromosome 6p12 in Spanish-Amerinds of Mexico. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439895     DOI: 10.1002/ajmg.10724

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Susceptibility Gene for Juvenile Myoclonic Epilepsy Rings True.

Authors:  Robyn Wallace
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

Review 2.  Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.

Authors:  Timothy E Welty
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Generalized Epilepsy and Myoclonic Seizures in 22q11.2 Deletion Syndrome.

Authors:  Vincent Strehlow; Marielle E M Swinkels; Rhys H Thomas; Nora Rapps; Steffen Syrbe; Thomas Dorn; Johannes R Lemke
Journal:  Mol Syndromol       Date:  2016-08-24

4.  DNA variants in coding region of EFHC1: SNPs do not associate with juvenile myoclonic epilepsy.

Authors:  Dongsheng Bai; Julia N Bailey; Reyna M Durón; María E Alonso; Marco T Medina; Iris E Martínez-Juárez; Toshimitsu Suzuki; Jesús Machado-Salas; Ricardo Ramos-Ramírez; Miyabi Tanaka; Ramón H Castro Ortega; Minerva López-Ruiz; Astrid Rasmussen; Adriana Ochoa; Aurelio Jara-Prado; Kazuhiro Yamakawa; Antonio V Delgado-Escueta
Journal:  Epilepsia       Date:  2009-05       Impact factor: 5.864

Review 5.  Evaluating candidate genes in common epilepsies and the nature of evidence.

Authors:  Deb K Pal; Lisa J Strug; David A Greenberg
Journal:  Epilepsia       Date:  2007-11-19       Impact factor: 5.864

6.  Advances in genetics of juvenile myoclonic epilepsies.

Authors:  Antonio V Delgado-Escueta
Journal:  Epilepsy Curr       Date:  2007 May-Jun       Impact factor: 7.500

7.  Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry.

Authors:  Ryan L Subaran; Juliette M Conte; William C L Stewart; David A Greenberg
Journal:  Epilepsia       Date:  2014-12-08       Impact factor: 5.864

Review 8.  Genetic and epigenetic mechanisms of epilepsy: a review.

Authors:  Tian Chen; Mohan Giri; Zhenyi Xia; Yadu Nanda Subedi; Yan Li
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-13       Impact factor: 2.570

9.  EFHC1 mutation in Indian juvenile myoclonic epilepsy patient.

Authors:  Romita Thounaojam; Leader Langbang; Kavish Itisham; Roohollah Sobhani; Shivani Srivastava; Bhargavi Ramanujam; Ramesh Verma; Manjari Tripathi; Kripamoy Aguan
Journal:  Epilepsia Open       Date:  2017-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.